In the town of Koltsovo, Siberia, Russia’s State Research Center for Virology has one of the world’s biggest collections of hazardous viruses. The lab-created biological weapons and defenses against them during the Cold War and it supposedly stored, amongst other viruses, hazardous strains of PLC, anthrax, and Ebola.
Many were also worried when on Monday an explosion hit the facility.
The laboratory was repaired as a gas bottle exploded, a 30 square meter fire sparked a workers ‘ severely burning, according to Russian independent media. Glass was supposedly demolished throughout the entire building and the fire would have spread through the ventilation system of the building.
Experts say an explosion may lead to the release of fatal pathogens under certain conditions. Joseph Kam, Associate Professor at the Stanley Ho Center for Emerging Infectious Diseases, Chinese University of Hong Kong, informed CNN that a part of the explosive force wave will be taken off the spot when it was initially stored.
This says that storage processes are highly rigorous for lethal pathogens such as pox. The Mayor of the town has said that the general people do not face any danger, and a center spokesman says in the space where the explosion happened, no dangerous pathogens are stored.
But they should not offer us a pause. This does not imply, however. Clear explosions are comparatively rare but catastrophic crashes that release hazardous pathogens are indeed shockingly prevalent–not only in Russia but also in the US and Europe. Slips with some of the most hazardous substances of the world happen hundreds of occasions each year from accidental exposures of smallpox and anthrax to miss-transmission of lethal flu strains.
What are we supposed to do? The response is not that we should reduce the number of lives saved by studies on virology and pathogen research. The current cocktail of Ebola therapy, which can reduce Ebola from the death penalty to mild, treatable illness, could be developed by researching the Ebola virus, for instance.
What should we do? The answer is certainly not to decrease the number of lives saved by virological and pathogenic study studies. For example, Ebola-Virus research could develop the current cocktail, which can reduce Ebola from death to mild, treatable disease.